HY004

· Juventas Cell Therapy Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HY004, covering 2025-08-08 to 2025-08-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HY004 Treatment in Adult Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r B-ALL) [Phase 1, Phase 2]

See pricing